coptisine has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y; Ding, K; Ding, Y; Hua, S; Huang, Y; Jiang, J; Li, M; Li, P; Ma, Y; Qiao, D; Yang, X; Yin, H; Yue, Q; Zeng, L; Zhao, M | 1 |
| Chen, J; Huang, Z; Li, C; Li, Y; Liang, Y; Liu, J; Luo, C; Ni, C; Su, Z; Wang, Y; Xie, J | 1 |
| Chen, H; Lai, X; Li, C; Lin, G; Luo, C; Su, Z; Tan, L; Wang, Y; Xie, J; Zeng, H | 1 |
| Fu, S; Hong, T; Ni, S; Wang, D | 1 |
| Du, GH; Fang, LH; Gong, LL; Guo, J; Li, L; Qin, HL; Wang, SB; Wu, YJ; Xu, XN; Yan, Y; Yuan, TY | 1 |
| Du, LS; He, XJ; Tao, BB; Yan, JK; Yang, Q; Yang, SS; Yang, YY; Yu, D; Zhu, YW | 1 |
| He, K; Hu, YR; Li, XG; Ma, H; Wang, YZ; Wu, H; Xia, S; Xue, DF; Ye, XL; Zou, ZY | 1 |
| Dou, L; Li, X; Song, Y; Wang, X; Xue, H; Yue, Y | 1 |
| Han, B; He, K; Huang, T; Li, L; Li, X; Ma, H; Tian, C; Wang, M; Wang, Y; Xiao, Y; Ye, X; Yi, L | 1 |
9 other study(ies) available for coptisine and Disease Models, Animal
| Article | Year |
|---|---|
N6-methyladenosine modification of TSC1 mRNA contributes to macrophage polarization regulated by Coptisine in DSS-induced ulcerative colitis.
Topics: Animals; Colitis; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; RNA, Messenger; Tuberous Sclerosis | 2024 |
Coptisine ameliorates DSS-induced ulcerative colitis via improving intestinal barrier dysfunction and suppressing inflammatory response.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Apoptosis Regulatory Proteins; Berberine; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Inflammation Mediators; Intestinal Mucosa; Male; Mice, Inbred C57BL; Permeability; Tight Junction Proteins; Tight Junctions | 2021 |
Protective effect of coptisine free base on indomethacin-induced gastric ulcers in rats: Characterization of potential molecular mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Berberine; Cyclooxygenase 1; Cyclooxygenase 2; Disease Models, Animal; Gastric Mucosa; Indomethacin; Interleukin-1beta; Lansoprazole; Male; p38 Mitogen-Activated Protein Kinases; Rats; Stomach Ulcer; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2018 |
Coptisine Suppresses Mast Cell Degranulation and Ovalbumin-Induced Allergic Rhinitis.
Topics: Animals; Berberine; beta-N-Acetylhexosaminidases; Cell Degranulation; Cell Line; Disease Models, Animal; Histamine; Immunoglobulin E; Interleukin-4; Mast Cells; Mice; Ovalbumin; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rhinitis, Allergic; Tumor Necrosis Factor-alpha | 2018 |
Coptisine protects rat heart against myocardial ischemia/reperfusion injury by suppressing myocardial apoptosis and inflammation.
Topics: Animals; Apoptosis; Berberine; Cytokines; Disease Models, Animal; Electrocardiography; Enzyme-Linked Immunosorbent Assay; Heart; Inflammation; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Rats; rho-Associated Kinases; Temperature; Time Factors | 2013 |
The IDO inhibitor coptisine ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Berberine; Brain; Cell Survival; Cognition; Cognition Disorders; Disease Models, Animal; Donepezil; Enzyme Inhibitors; Humans; Indans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Mice, Transgenic; Nootropic Agents; PC12 Cells; Piperidines; Plaque, Amyloid; Presenilin-1; Rats | 2015 |
Coptisine attenuates obesity-related inflammation through LPS/TLR-4-mediated signaling pathway in Syrian golden hamsters.
Topics: Animals; Berberine; Body Weight; Cholesterol; Cholesterol, LDL; Coptis; Diet, High-Fat; Disease Models, Animal; Inflammation; Interleukin-6; Lipid Metabolism; Lipid-Linked Proteins; Lipopolysaccharides; Male; Mesocricetus; Molecular Structure; Obesity; Signal Transduction; Toll-Like Receptor 4; Triglycerides; Tumor Necrosis Factor-alpha | 2015 |
Screening β1AR inhibitors by cell membrane chromatography and offline UPLC/MS method for protecting myocardial ischemia.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Apoptosis; Berberine; Binding, Competitive; Cell Membrane; CHO Cells; Chromatography, High Pressure Liquid; Coptis; Cricetulus; Disease Models, Animal; Male; Malondialdehyde; Mass Spectrometry; Metoprolol; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Phytotherapy; Plant Extracts; Plants, Medicinal; Rats, Wistar; Receptors, Adrenergic, beta-1; Superoxide Dismutase; Transfection | 2015 |
Coptisine from Rhizoma Coptidis Suppresses HCT-116 Cells-related Tumor Growth in vitro and in vivo.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Araceae; Berberine; Cell Proliferation; Colorectal Neoplasms; Disease Models, Animal; HCT116 Cells; Heterografts; Humans; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Treatment Outcome | 2017 |